Neuroprotective effect of γ-glutamylethylamide (theanine) on cerebral infarction in mice

Neuroscience Letters

Volumn 363, Issue 1, 2004, Pages 58-61

  Egashira, Nobuaki ^a   Hayakawa, Kazuhide ^a   Mishima, Kenichi ^a   Kimura, Hitomi ^a   Iwasaki, Katsunori ^a   Fujiwara, Michihiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Glutamylethylamide; Focal cerebral ischemia; Middle cerebral artery; Neuroprotection; Theanine

Indexed keywords

AMIDE; GAMMA GLUTAMYLETHYLAMIDE; GLUTAMIC ACID DERIVATIVE; THEANINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN TEMPERATURE; CARBON DIOXIDE TENSION; CONTROLLED STUDY; EXPERIMENTAL MODEL; HEMATOCRIT; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; OXYGEN TENSION; PH; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANALYSIS OF VARIANCE; ANIMALS; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAMATES; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; NEUROPROTECTIVE AGENTS; TETRAZOLIUM SALTS;

EID: 2442592793     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.03.046     Document Type: Article

References (20)

1. Arias R.L., Tasse J.R.P., Bowlby M.R. Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia. Brain Res. 816:1999;299-308
2. Buchan A.M., Slivka A., Xue D. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Res. 574:1992;171-177
3. Iwasaki K., Chung E.-H., Egashira N., Hatip-Al-Khatib I., Mishima K., Egawa T., Irie K., Fujiwara M. Non-NMDA mechanism in the inhibition of cellular apoptosis and memory impairment induced by repeated ischemia in rats. Brain Res. 995:2004;131-139
4. Izumisawa N., Kawakami A., Ohata T., Hanada T., Okeda R. YM90K, an AMPA antagonist, has no neurotoxic effects on cerebrocortical neurons in rats. Exp. Neurol. 134:1995;199-204
5. 3H] MDL 105519 to glutamate receptors. Biosci. Biotechnol. Biochem. 66:2002;2683-2686
6. Kakuda T., Yanase H., Utsunomiya K., Nozawa A., Unno T., Kataoka K. Protective effect of γ-glutamylethylamide (theanine) on ischemic delayed neuronal death in gerbils. Neurosci. Lett. 289:2000;189-192
7. Kawasaki-Yatsugi S., Ichiki C., Yatsugi S.-I., Shimizu-Samata M., Yamaguchi T. YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;586-591
8. Kawasaki-Yatsugi S., Yatsugi S.-I., Koshiya K., Shimizu-Sasamata M. Neuroprotective effect of YM-90K, an AMPA receptor antagonist, against delayed neuronal death induced by global cerebral ischemia in gerbils and rats. Jpn. J. Pharmacol. 74:1997;253-260
9. Kimura R., Murata T. Influence of alkylamides of glutamic acid and related compounds on the central nervous system I. Central depressant effect of theanine. Chem. Pharm. Bull. 19:1971;1257-1261
10. 3H] MK801 binding to synaptic membranes from rat central nervous system. Comp. Biochem. Physiol. 107C:1994;105-110
11. Mishima K., Tanaka T., Pu F., Egashira N., Iwasaki K., Hidaka R., Matsunaga K., Takata J., Karube Y., Fujiwara M. Vitamin E isoforms α-tocotrienol and γ-tocopherol prevent cerebral infarction in mice. Neurosci. Lett. 337:2003;56-60
12. Sato A., Uchida S., Yamauchi Y. A new method for continuous measurement of regional cerebral blood flow using laser Doppler flowmetry in a conscious rat. Neurosci. Lett. 175:1994;149-152
13. Sheardown M.J., Suzak P.D., Nordholm L. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil ischemia, even when delayed 24 h. Eur. J. Pharmacol. 236:1993;347-353
14. Terashima T., Takido J., Yokogoshi H. Time-dependent changes of amino acids in the serum, liver, brain and urine of rats administered with theanine. Biosci. Biotechnol. Biochem. 63:1999;615-618
15. Umemura K., Shimakura A., Nakashima M. Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia. Brain Res. 773:1997;61-65
16. Xue D., Huang Z.G., Barnes K., Lesiuk H.J., Smith K.E., Buchan A.M. Delayed treatment with AMPA, but not NMDA, antagonist reduces neocortical infarction. J. Cereb. Blood Flow Metab. 14:1994;251-261
17. Yao H., Ibayashi S., Nakane H., Cai H., Uchimura H., Fujishima M. AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats. Brain Res. 753:1997;80-85
18. Yokogoshi H., Kato Y., Sagesaka Y.M., Takihara-Matsuura T., Kakuda T., Takeuchi N. Reduction effect of theanine on blood pressure and brain 5-hydroxyindoles in spontaneously hypertensive rats. Biosci. Biotech. Biochem. 59:1995;615-618
19. Yokogoshi H., Kobayashi M., Mochizuki M., Terashima T. Effect of theanine, γ-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem. Res. 23:1998;667-673
20. Yokozawa T., Dong E. Influence of green tea and its three major components upon low-density lipoprotein oxidation. Exp. Toxicol. Pathol. 49:1997;329-335